|
[1]
|
Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
Drugs in R&D,
2017
DOI:10.1007/s40268-016-0161-9
|
|
|
|
|
[2]
|
Protective effects of methanolic extract of Adhatoda vasica Nees leaf in collagen-induced arthritis by modulation of synovial toll-like receptor-2 expression and release of pro-inflammatory mediators
Journal of Nutrition & Intermediary Metabolism,
2016
DOI:10.1016/j.jnim.2015.11.001
|
|
|
|
|
[3]
|
Identification of p38β as a Therapeutic Target for the Treatment of Sézary Syndrome
Journal of Investigative Dermatology,
2015
DOI:10.1038/jid.2014.367
|
|
|
|
|
[4]
|
Toll-like receptor 2 and 6 interdependency in the erosive stage of Staphylococcus aureus induced septic arthritis mediated by IFN-γ and IL-6 – A possible involvement of IL-17 in the progression of the disease
Immunobiology,
2015
DOI:10.1016/j.imbio.2015.01.012
|
|
|
|
|
[5]
|
A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
Critical Care Medicine,
2015
DOI:10.1097/CCM.0000000000001132
|
|
|
|
|
[6]
|
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach
Journal of Psychopharmacology,
2014
DOI:10.1177/0269881114529377
|
|
|
|
|
[7]
|
A Low‐Frequency Variant in
MAPK14
Provides Mechanistic Evidence of a Link With Myeloperoxidase: A Prognostic Cardiovascular Risk Marker
Journal of the American Heart Association,
2014
DOI:10.1161/JAHA.114.001074
|
|
|
|
|
[8]
|
Population Pharmacokinetics of Losmapimod in Healthy Subjects and Patients with Rheumatoid Arthritis and Chronic Obstructive Pulmonary Diseases
Clinical Pharmacokinetics,
2013
DOI:10.1007/s40262-012-0025-6
|
|
|
|